文献速递细菌感染、耐药与抗菌药物医院感染防控

脓毒症与严重感染中抗菌治疗疗程的叙述性综述

Antimicrobial Treatment Duration in Sepsis and Serious Infections.
PubMed 文献 · J Infect Dis · 2020-01-01

脓毒症死亡率因早期识别和标准化管理而改善,但抗菌疗程指导有限。减少抗生素暴露与较低的新发耐药、艰难梭菌感染、毒性及费用相关。本文叙述性综述证据以指导脓毒症抗生素疗程,但证据受非劣效试验设计及排除危重患者限制。

要点

  • 减少抗生素暴露可降低耐药、艰难梭菌感染、毒性和费用。
  • 脓毒症短疗程证据受非劣效设计及排除危重患者限制。
  • 源头控制不足、耐药菌和药代动力学改变是短疗程挑战。

核心结论

  • 脓毒症抗菌疗程指导有限,需更多针对脓毒症临床指标患者的研究。
  • 减少抗生素暴露与较低耐药、艰难梭菌感染、毒性和费用相关。

研究设计与样本

  • 叙述性综述,评估脓毒症抗生素疗程证据。

主要发现

  • 证据显著受非劣效试验设计和许多试验排除危重患者限制。
  • 短疗程挑战包括源头控制不足、耐药菌治疗和药代动力学改变。

临床怎么用

  • 临床需权衡短疗程安全性与充分性,考虑源头控制、耐药菌和药代动力学。

局限性

  • 证据受非劣效试验设计和排除危重患者限制。
  • 需针对脓毒症临床指标患者的额外研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sepsis mortality has improved following advancements in early recognition and standardized management, including emphasis on early administration of appropriate antimicrobials. However, guidance regarding antimicrobial duration in sepsis is surprisingly limited. Decreased antibiotic exposure is associated with lower rates of de novo resistance development, Clostridioides difficile-associated disease, antibiotic-related toxicities, and health care costs. Consequently, data weighing safety versus adequacy of shorter treatment durations in sepsis would be beneficial. We provide a narrative review of evidence to guide antibiotic duration in sepsis. Evidence is significantly limited by noninferiority trial designs and exclusion of critically ill patients in many trials. Potential challenges to shorter antimicrobial duration in sepsis include inadequate source control, treatment of multidrug-resistant organisms, and pharmacokinetic alterations that predispose to inadequate antimicrobial levels. Additional studies specifically targeting patients with clinical indicators of sepsis are needed to guide measures to safely reduce antimicrobial exposure in this high-risk population while preserving clinical effectiveness.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Busch LM, Kadri SS. Antimicrobial Treatment Duration in Sepsis and Serious Infections. J Infect Dis. 2020. PMID: 32691838. doi:10.1093/infdis/jiaa247

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。